Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients

Journal of the National Cancer Institute
J T FarrarE Nordbrock

Abstract

Patients with cancer frequently experience episodes of acute pain, i.e., breakthrough pain, superimposed on their chronic pain. Breakthrough pain is usually treated with short-acting oral opioids, most of which provide some relief after 15-20 minutes, with peak effects after 30-45 minutes. Oral transmucosal fentanyl citrate (OTFC), a unique formulation of the opioid fentanyl, has been shown to provide meaningful pain relief within 5 minutes in patients following surgery. We conducted a multicenter, randomized, double-blinded, placebo-controlled trial of OTFC for cancer-related breakthrough pain. Patients who were 18 years of age or older, receiving the equivalent of at least 60 mg oral morphine or at least 50 microg transdermal fentanyl per day for chronic cancer-related pain, and experiencing at least one episode of breakthrough pain per day were studied. After titration to an effective OTFC dose, subjects were given 10 randomly ordered treatment units (seven OTFC units and three placebo units) in the form of identical lozenges. If acceptable pain relief was not achieved within 30 minutes, subjects were instructed to take their previous breakthrough pain medication (i.e., rescue medication). Pain intensity, pain relief, and us...Continue Reading

References

May 1, 1992·Current Problems in Cancer·V C Jordan
Jun 1, 1990·Pain·R K Portenoy, N A Hagen
Aug 1, 1991·Anesthesiology·J B StreisandT H Stanley
Jul 1, 1989·Anesthesia and Analgesia·T H StanleyM A Ashburn
Jan 1, 1982·Acta Anaesthesiologica Scandinavica. Supplementum·R W Houde
Mar 3, 1994·The New England Journal of Medicine·A JacoxR Payne
May 1, 1994·Pain·Franco de ConnoVittorio Vcntafridda
Jun 1, 1997·Anesthesia and Analgesia·W D Ngan Kee

❮ Previous
Next ❯

Citations

Jul 16, 2008·Current Pain and Headache Reports·Neil A HagenCarla Stiles
Mar 23, 2011·Current Pain and Headache Reports·Sebastiano Mercadante
Dec 25, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Y EscobarJ J Cruz
Jun 19, 2001·Primary Care·J L Abrahm, L Snyder
Feb 27, 2003·Ultrasound in Medicine & Biology·Morton W MillerE Carr Everbach
Feb 21, 2002·Neurologic Clinics·A C Carver, K M Foley
Sep 16, 2000·Journal of Pain and Symptom Management·D J Casarett, J H Karlawish
Apr 20, 2001·Journal of Pain and Symptom Management·S Mercadante, R K Portenoy
Aug 23, 2001·Journal of Pain and Symptom Management·R PayneR K Portenoy
Aug 16, 2001·Journal of Pain and Symptom Management·J Gardner-Nix
Sep 29, 2001·Journal of Pain and Symptom Management·B GagnonE D Bruera
Aug 17, 2002·Journal of Pain and Symptom Management·Xavier Gómez-BatisteHelena Camell
Jan 29, 2003·Journal of Pain and Symptom Management·Hilary PavisAnthony Fisher
May 3, 2003·Journal of Pain and Symptom Management·John T FarrarBrian L Strom
Jul 10, 2003·Journal of Pain and Symptom Management·David J CasarettKaren B Hirschman
Oct 14, 1998·Journal of Pain and Symptom Management·P G Fine, M A Busch
May 15, 2002·Critical Reviews in Oncology/hematology·Marcello De CiccoCristina Santantonio
Jul 23, 2002·Journal of Palliative Medicine·David J CasarettKaren B Hirschman
Feb 28, 2006·Journal of Palliative Medicine·David Casarett
May 3, 2007·Journal of Palliative Medicine·Neil A HagenCarla Stiles
Dec 22, 2007·Journal of Palliative Medicine·James F Cleary
Nov 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R RauckA L Finn
Jan 2, 2003·Journal of the National Cancer Institute·Gisèle Chvetzoff, Ian F Tannock
Apr 25, 2013·QJM : Monthly Journal of the Association of Physicians·K McWilliams, M Fallon
Apr 16, 2010·The Clinical Journal of Pain·Sebastiano MercadanteAlessandra Casuccio
Jun 5, 2007·Current Opinion in Oncology·Sebastiano Mercadante, Fabio Fulfaro
May 22, 2010·Current Opinion in Oncology·Dominique A Lossignol, Cristina Dumitrescu
Jan 1, 2009·Journal of Pain Research·Joanne Droney, Julia Riley
Aug 29, 2007·International Journal of Nanomedicine·Kyriaki MystakidouLambros Vlahos
Feb 11, 2000·Clinical Pharmacokinetics·S GrondK A Lehmann
Jul 20, 2002·Clinical Pharmacokinetics·Hao ZhangJames B Streisand
Jul 4, 2001·Drugs·C Ripamonti, E D Dickerson
May 7, 2008·Drugs·Leeroy William, Rod Macleod
Jan 12, 2012·Drugs·Sebastiano Mercadante
Apr 3, 2012·Drugs & Aging·Eric Prommer, Brandy Ficek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.